Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Apr 15, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Southern Regional Workshop on Sexual and Gender Minority (SGM)-Related Research
National Institutes of Health - Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements
National Institutes of Health - Notice of Change in Expiration Date of PAR-19-229 "Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed)"
National Institute of Allergy and Infectious Diseases - Notice of NIAID's Participation in RFA-OD-19-020 "Building Interdisciplinary Research Careers in Women's Health (K12 Clinical Trial Optional)"
National Institute of Allergy and Infectious Diseases - Notice of NIAMS Participation in PA-18-837: Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Notice of Preapplication Webinar for Administrative Supplements for Activities to Promote Human Immune-Representing Oncology Models
National Cancer Institute - Pre-Application Webinar for RFA-CA-19-035, Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required)
National Cancer Institute - Notice of Correction to Eligibility Information in PAR-18-947 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)"
National Cancer Institute - Notice of Upcoming Webinar for the NCI Office of Cancer Survivorship
National Cancer Institute - Notice of Correction to Award Information in RFA-CA-19-040 "Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Cancer Institute - Notice of Correction to Award Information in RFA-CA-19-041 "Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)"
National Cancer Institute - Notice of Correction to RFA-CA-19-047 "SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)"
National Cancer Institute - Notice of Correction to PAR-19-223, "Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of Correction to RFA-DA-20-002 "Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Linked Research Project Sites (Collaborative U01 Clinical Trial Not Allowed)"
National Institute on Drug Abuse - Notice of NIDCR Participation in Building Interdisciplinary Research Careers in Women's Health (K12 Clinical Trial Optional)
National Institute of Dental and Craniofacial Research - Notice of NIDDK's Participation in PA-19-196 "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)
National Institute of Diabetes and Digestive and Kidney Diseases - Notice to Change the Application Due Date for PAR-19-190 - "Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional"
Food and Drug Administration - Notice of Clarification of Institutional Eligibility for PAR-19-102 Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
National Institute of General Medical Sciences - Notice of Clarification of Institutional Eligibility for PAR-19-219 Maximizing Access to Research Careers (T34)
National Institute of General Medical Sciences - Notice of Clarification of Institutional Eligibility for PAR-19-218 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
National Institute of General Medical Sciences - NICHD Guidance for Investigator-initiated Basic Experimental Studies Involving Humans (BESH) That Meet NIH's Definition of a Clinical Trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Change to Eligibility Information and Key Dates in RFA-HL-20-009 "BLOODSAFE (UG3/UH3 Clinical Trial Optional)" and Announcement of Availability of FAQs
National Heart, Lung, and Blood Institute - Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-003: "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
National Heart, Lung, and Blood Institute - Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-004 "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Research Coordinating Center (U24)"
National Heart, Lung, and Blood Institute - Notice of Change to Key Dates in RFA-HL-20-010 "BLOODSAFE (U24 Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute - Oversight and Monitoring of Clinical Research funded by the NIMH
National Institute of Mental Health - Notice of Intent to Publish the Reissuance of "RFA-NS-19-025" "HEAL Initiative: Early Phase Pain Investigation Clinical Network - Specialized Clinical Centers (U24 Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke - Notice of Correction to Application Types Allowed for RFA-NS-19-017 "HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke - Notice of Change to Key Dates for RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Nursing Research - Notice of Change to Key Dates for RFA-NS-19-017 "HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Nursing Research
Office of Research on Women's Health - Notice of Change to Key Dates for RFA-NS-19-018 "HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Nursing Research
Office of Research on Women's Health - Notice of Change to Key Dates for RFA-EB-18-003 "HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Cancer Institute
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases - Notice of Change to Response Date for NOT-NS-19-045 " Request for Information: Soliciting Input on How Best to Advance Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Research"
National Institute of Neurological Disorders and Stroke - Updates for PAR-18-812 Occupational Safety and Health Research (R01)
National Institute for Occupational Safety and Health - Updates for PAR-18-797 Occupational Safety and Health Research (R03)
National Institute for Occupational Safety and Health - Updates for PAR-18-798 NIOSH Exploratory/Developmental Research Grant Program (R21)
National Institute for Occupational Safety and Health
Requests for Applications
- Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
National Cancer Institute
- Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities. (U01) Clinical Trial Not Allowed
Food and Drug Administration
- Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional)
National Heart, Lung, and Blood Institute
National Institute of Neurological Disorders and Stroke
- BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
- BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Building Interdisciplinary Research Careers in Women's Health (BIRCWH); K12 Clinical Trial Optional
Office of Research on Women's Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Program Announcements
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
National Cancer Institute
- International Bioethics Research Training Program (D43 Clinical Trial Optional)
- International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
John E. Fogarty International Center
National Human Genome Research Institute
- Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)
National Institute on Drug Abuse
- Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed)
- Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed)
National Institute on Aging
National Institute of Environmental Health Sciences
Office of Behavioral and Social Science Research
- Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Populations (R01 Clinical Trial Optional)
National Institute of Environmental Health Sciences
National Institute on Aging
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Science Research
- Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)
- Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)
National Cancer Institute
National Institute of Environmental Health Sciences
- Focused Technology Research and Development (R01 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
- Exploratory Research for Technology Development (R21 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu